IL2 and renal cell carcinoma: However, when the ccA/ccB classifier is applied to the HD-IL2 treated patients with RCC from the current study, the ccB subtype patients no longer have a worse OS (P = 0.7; Fig. 3C); however, the small sample size may contribute to the closing of the survival curves for the HD-IL2 patients.